Valuation Provectus Biopharmaceuticals, Inc.

Stocks

Market Closed - OTC Markets 01:07:28 03/06/2026 am IST			5-day change	1st Jan Change
0.0620 ^USD	-7.32%		+12.73%	+10.91%

13/08	Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07/07	Provectus Biopharmaceuticals, Inc. Highlights Peer-Reviewed Study Demonstrating Opposing Mechanistic Effects Of Rose Bengal Sodium At The Same Dose	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	23.43	23.07	45.43	40.27	50.48	23.49
Change	-	-1.55%	96.93%	-11.35%	25.33%	-53.46%
Enterprise Value (EV) ¹	47.13	24.13	47.59	43.22	53.35	26.22
Change	-	-48.8%	97.24%	-9.18%	23.43%	-50.85%
P/E	-3.44x	-4.05x	-12.8x	-13x	-10.6x	-4.33x
PBR	-0.77x	-5.48x	-7.27x	-5.29x	-8.45x	-3.72x
PEG	-	0.2x	0.3x	1x	-0.2x	-0.3x
Capitalization / Revenue	-	-	4,59,34,892x	7,22,13,378x	8,17,89,566x	6,98,99,095x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-10x	-5.21x	-14.1x	-17.4x	-13.5x	-5.41x
EV / EBIT	-9.55x	-5.2x	-14x	-17.3x	-13.5x	-5.41x
EV / FCF	44.5x	-3.48x	-39.6x	-37.2x	-18.2x	-19.6x
FCF Yield	2.25%	-28.8%	-2.53%	-2.68%	-5.5%	-5.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.017	-0.0136	-0.008474	-0.007393	-0.0113	-0.0129
Distribution rate	-	-	-	-	-	-
Net sales	-	-	0.989	0.5577	0.6171	0.3361
EBITDA ¹	-4.694	-4.628	-3.38	-2.489	-3.939	-4.842
EBIT ¹	-4.936	-4.641	-3.391	-2.498	-3.946	-4.844
Net income ¹	-6.678	-5.54	-3.555	-3.102	-4.762	-5.431
Net Debt ¹	23.7	1.061	2.163	2.95	2.877	2.727
Reference price ²	0.0584	0.0550	0.1083	0.0960	0.1201	0.0559
Nbr of stocks (in thousands)	4,01,232	4,19,447	4,19,497	4,19,522	4,20,280	4,20,280
Announcement Date	02/03/21	29/03/22	30/03/23	28/03/24	28/03/25	26/03/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PROVECTUS BIOPHARMACEUTICALS, INC.	-	-	-	-	2.4Cr
WUXI APPTEC CO., LTD.	21.73x	7.77x	15.61x	1.37%	7.45TCr
ARGENX SE	31.25x	9.01x	28.06x	0.04%	6.01TCr
LONZA GROUP AG	33.64x	6.03x	18.07x	0.97%	4.82TCr
IQVIA HOLDINGS INC.	34.63x	3.34x	14.4x	-.--%	4.43TCr
REVOLUTION MEDICINES, INC.	-21.16x	229.18x	-22.81x	-.--%	4.4TCr
BEONE MEDICINES AG	47.94x	5.54x	30.43x	-.--%	4.16TCr
CELLTRION, INC.	26.89x	7.76x	19.96x	0.42%	3TCr
WUXI BIOLOGICS (CAYMAN) INC.	33.91x	7.26x	18.84x	-.--%	2.93TCr
INSMED INCORPORATED	-70.02x	13.44x	-68.51x	-.--%	2.49TCr
Average	15.42x	32.15x	6.01x	0.31%	3.97TCr
Weighted average by Cap.	19.58x	31.88x	10.24x	0.41%